CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 1 USD -0.99% Market Closed
Market Cap: 78.1m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

CytomX Therapeutics Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CytomX Therapeutics Inc
Other Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
CytomX Therapeutics Inc
NASDAQ:CTMX
Other Equity
$40k
CAGR 3-Years
-26%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Equity
-$2.3B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-10%
Gilead Sciences Inc
NASDAQ:GILD
Other Equity
$18.4B
CAGR 3-Years
526%
CAGR 5-Years
175%
CAGR 10-Years
61%
Amgen Inc
NASDAQ:AMGN
Other Equity
-$336m
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Equity
$15.6B
CAGR 3-Years
992%
CAGR 5-Years
287%
CAGR 10-Years
163%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Equity
$60.2m
CAGR 3-Years
82%
CAGR 5-Years
29%
CAGR 10-Years
8%

See Also

What is CytomX Therapeutics Inc's Other Equity?
Other Equity
40k USD

Based on the financial report for Sep 30, 2024, CytomX Therapeutics Inc's Other Equity amounts to 40k USD.

What is CytomX Therapeutics Inc's Other Equity growth rate?
Other Equity CAGR 5Y
-17%

The average annual Other Equity growth rates for CytomX Therapeutics Inc have been -26% over the past three years , -17% over the past five years .

Back to Top